241 results
DEFA14A
FRTX
Fresh Tracks Therapeutics, Inc.
18 Dec 23
Additional proxy soliciting materials
9:18am
the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that the Staff, pursuant to Nasdaq … disclosed, on October 10, 2023, the Company received a notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC
8-K
FRTX
Fresh Tracks Therapeutics, Inc.
18 Dec 23
Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th
8:21am
a notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that the Staff
8-K
EX-99.1
FRTX
Fresh Tracks Therapeutics, Inc.
18 Dec 23
Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th
8:21am
Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that the Staff, pursuant to Nasdaq Listing Rule Series 5100, had
8-K
kn9pqwgr
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:03pm
8-K
EX-10.1
uuwfgmyrv5z
10 Oct 23
Departure of Directors or Certain Officers
4:49pm
8-K
ke2sgxm
27 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:04pm